A dose of 250 mg/kg body weight, given twice daily for 40 days to laboratory mice, myricetin depicted glucoregulatory activity through agonizing the GLP-1 receptor, suggesting that the substance may have potential anti-type 2 diabetes mellitus effects [153]. Here, GLP1R is linked to diabetes mellitus.